Central Lung SBRT in Severe Emphysema: Coverage Versus Chest Wall Dose
A 74-year-old man with biopsy-proven squamous cell carcinoma of the right upper lobe, 2.6 cm, PET avid (SUVmax 9.1), no nodal or distant uptake, is referred for stereotactic body radiotherapy. He has severe emphysema (FEV1 1.05 L, DLCO 38% predicted), uses 2 L/min oxygen at night, and has a chronic productive cough. The tumor is central, abutting the right main bronchus and within 8 mm of the esophagus; the PTV is 3.2 cm. The prescribed dose is 50 Gy in 5 fractions. The plan achieves PTV D95 = 48.1 Gy, spinal cord D0.1cc = 27.8 Gy, esophagus D5cc = 30.9 Gy, and brachial plexus Dmax = 29.5 Gy, but chest wall V30 Gy = 52 cc and rib Dmax = 61 Gy. The patient asks whether the plan is safe and whether a less aggressive dose would be wiser given his lungs.
1. Evaluate whether this SBRT plan is acceptable. Identify which dosimetric deviations matter most and how you would counsel the patient about the trade-off between local control and toxicity.
Read the worked answer
Assessment. PTV D95 of 48.1 Gy is 96.2% of the 50 Gy prescription; for a central 5-fraction SBRT plan this is generally acceptable if coverage is not achieved by pushing critical organs at risk. The cord, esophagus, and brachial plexus values are within commonly used 5-fraction limits (cord D0.1cc ≤30 Gy, esophagus D5cc ≤32 Gy, brachial plexus Dmax ≤30 Gy), so they are not the main issue. The chest wall V30 of 52 cc and rib Dmax of 61 Gy are the meaningful deviations: rib fracture risk rises with high-dose chest wall volume and maximum rib dose, and a central tumor often forces beams through chest wall. Severe emphysema and interstitial lung disease do not change spinal cord tolerance, but they increase the risk of symptomatic radiation pneumonitis and reduce pulmonary reserve. Judgment. I would accept the plan only if repeat optimization cannot reduce chest wall/rib dose while maintaining PTV D95 ≥95% and organ-at-risk limits; document the rib-fracture and pulmonary risks, and counsel that local control is the priority but that dropping to a lower dose per fraction would change tumor radiobiology and is not automatically safer for the chest wall. Counseling. Explain that the main trade-off is local control versus a modest rib fracture risk, not cord injury, and that his lung disease makes any pneumonitis more dangerous.
2. If repeat planning cannot reduce chest wall V30 below 50 cc without compromising PTV coverage, what alternative strategies would you consider, and how would you justify them?
Read the worked answer
Options include: (1) non-coplanar beam arrangement or VMAT arc avoidance to keep high-dose paths off the rib; (2) motion management with abdominal compression or gating to shrink the internal target volume and allow tighter margins; (3) proton therapy if available, because the Bragg peak can spare chest wall, though central airway proximity and motion require robust planning; (4) accepting the chest wall dose after documenting that the alternative is a high-risk untreated central squamous cell carcinoma. I would not simply cut PTV coverage to spare rib. Justify by comparing nominal tumor control probability and rib fracture risk: for a 2.6 cm central tumor, 50 Gy in 5 fractions gives high local control, and a rib fracture is usually manageable, whereas a marginal miss can cause airway obstruction or hemoptysis. If the patient prioritizes avoiding fracture, discuss a lower-dose palliative approach explicitly, but do not present it as equivalent.